Bison Wealth, LLC Otonomy, Inc. Transaction History

Bison Wealth, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 09, 2018	SELL	$2.6 - $3.95 $13,780 - $20,935	-5,300 Reduced 34.64%	10,000 $28,000
Q2 2018 Aug 09, 2018	SELL	$3.7 - $4.75 $68,450 - $87,875	-18,500 Reduced 54.73%	15,300 $59,000
Q1 2018 May 08, 2018	BUY	$4.05 - $6.1 $31,590 - $47,580	7,800 Added 30.0%	33,800 $142,000
Q4 2017 Jan 29, 2018	SELL	$2.8 - $5.55 $30,799 - $61,050	-11,000 Reduced 29.73%	26,000 $144,000
Q3 2017 Oct 27, 2017	BUY	$3.2 - $20.8 $118,400 - $769,600	37,000	37,000 $120,000

Ticker OTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,990,400
Description
Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurot...

Get notified when there are updates to the investment portfolio of Bison Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Bison Wealth, LLC with notifications on news.